3-chloro-4-fluoro-3'-piperidinomethyl benzophenone, 97.0%, 1g

Ethyl 1-methylcyclopropanecarboxylate, 95.0%, 1g

Bismuth(III) nitrate, min. 71% Bi, pa, basic, 100 g, plastic packaging.

(5-Amino-2-fluorophenyl)methanol, 95.0%, 10g

Microliter syringe GASTIGHT® series 1000, 1.0 ml, 1001 TLL, 1 piece

5-Bromo-1,3-dichloro-2-fluorobenzene, 98.0%, 1g

1,5-Dihydro-1,5-naphthyridine-2,6-dione, 98%, 250mg

5'-O-(4,4'-DIMETHOXYTRITYL)URIDINE, 95%, 5g

3,6-Dichloro-2-methoxypyridine, 96%, 25g

1-Ethyl-1H-imidazole-2-carbaldehyde, 95.0%, 5g

2-Cyclohexyl-5-methylphenol>97.0%(GC)10g

1-[(5-bromothiophen-2-yl)sulfonyl]piperazine (hydrochloride), 250mg

3'-Chlorophenyl acetylene, 97.0%, 1g